|
| Cyclin D1 Induces Chromosomal Instability |
|
https://doi.org/10.18632/oncotarget.476
Mathew C. Casimiro, and Richard G. Pestell
|
| 224-225 |
|
| Double Agents in the War on Cancer: Leukocytes Govern Ovarian Cancer Progression |
|
https://doi.org/10.18632/oncotarget.478
Uciane K. Scarlett, and Jose R. Conejo-Garcia
|
| 226-227 |
|
| Regulation of p53: a collaboration between Mdm2 and Mdmx |
|
https://doi.org/10.18632/oncotarget.443
Dongsheng Pei, Yanping Zhang, and Junnian Zheng
|
| 228-235 |
|
| Targeted therapy for hepatocellular carcinoma: novel agents on the horizon |
|
https://doi.org/10.18632/oncotarget.466
Melchiorre Cervello, James A McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, and Giuseppe Montalto
|
| 236-260 |
|
| Essential role for telomerase in chronic myeloid leukemia induced by BCRABL in mice |
|
https://doi.org/10.18632/oncotarget.461
Carolina Vicente-Dueñas, Marcos Barajas-Diego, Isabel Romero-Camarero, Ines Gonzalez-Herrero, Teresa Flores, and Isidro Sanchez-Garcia
|
| 261-266 |
|
| Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis |
|
https://doi.org/10.18632/oncotarget.451
George S. Karagiannis, Constantina Petraki, Ioannis Prassas, Punit Saraon, Natasha Musrap, Apostolos Dimitromanolakis, and Eleftherios P. Diamandis
|
| 267-285 |
|
| Expressions of matrix metalloproteinase9 MMP9 dentin sialophosphoprotein DSPP and osteopontin OPN at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.373
Kalu U. E. Ogbureke, Paul M. Weinberger, Stephen W. Lonney, Li Li, and Larry W. Fisher
|
| 286-298 |
|
| BRCA1/p220 loss triggers BRCA1IRIS overexpression via mRNA stabilization in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.462
Yoshiko Shimizu, Nicole Mullins, Zannel Blanchard, and Wael M. ElShamy
|
| 299-313 |
|
| Overexpression of Thioredoxin1 mediates growth survival and chemoresistance and is a druggable target in diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.463
Changping Li, Michael A. Thompson, Archito T. Tamayo, Zhuang Zuo, John Lee, Francisco Vega, Richard J. Ford, and Lan V. Pham
|
| 314-326 |
|
| Stratification of Wilms tumor by genetic and epigenetic analysis |
|
https://doi.org/10.18632/oncotarget.468
Richard H. Scott, Anne Murray, Linda Baskcomb, Clare Turnbull, Chey Loveday, Reem Al-Saadi, Richard Williams, Fin Breatnach, Mary Gerrard, Juliet Hale, Janice Kohler, Pablo Lapunzina, Gill A. Levitt, Sue Picton, Barry Pizer, Milind D. Ronghe, Heidi Traunecker, Denise Williams, Anna Kelsey, Gordan M. Vujanic, Neil J. Sebire, Paul Grundy, Charles A. Stiller, Kathy Pritchard-Jones, Jenny Douglas, and Nazneen Rahman
|
| 327-335 |
|
| The Expression of pSTAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival |
|
https://doi.org/10.18632/oncotarget.475
Ian Lee, Patricia S. Fox, Sherise D. Ferguson, Roland L. Bassett, Jr., Ling-Yuan Kong, Christopher W. Schacherer, Jeffrey E. Gershenwald, Elizabeth A. Grimm, Gregory N. Fuller, and Amy B. Heimberger
|
| 336-344 |
|
| Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptorγ Enhances the Chemopreventive Effect of Anti-Estrogen |
|
https://doi.org/10.18632/oncotarget.457
Hongyan Yuan, Levy Kopelovich, Yuzhi Yin, Jin Lu, and Robert I Glazer
|
| 345-358 |
